Allogene Therapeutics, Inc. - COM (ALLO)

Historical Portfolio Holders from Q1 2016 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
131 M
Holdings value Q1 2024
$584 M
Value change Q1 2024
+$46.1 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
151
Number of buys Q1 2024
72
Number of sells Q1 2024
-74
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
0%
CUSIP
019770106
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 131 M $586 M +$46.1 M $4.47 153
2023 Q4 121 M $390 M -$23.5 M $3.21 165
2023 Q3 129 M $408 M -$15.8 M $3.17 149
2023 Q2 131 M $651 M +$76.3 M $4.97 164
2023 Q1 116 M $571 M +$24.7 M $4.94 172
2022 Q4 111 M $698 M +$15.8 M $6.29 160
2022 Q3 102 M $1.1 B +$63 M $10.80 177
2022 Q2 96.2 M $1.1 B +$100 M $11.40 149
2022 Q1 91.6 M $835 M +$16.4 M $9.11 169
2021 Q4 85.7 M $1.28 B -$105 M $14.92 164
2021 Q3 86.1 M $2.21 B +$36.2 M $25.70 161
2021 Q2 86.3 M $2.25 B -$84.5 M $26.08 177
2021 Q1 86.5 M $3.05 B -$11 M $35.30 166
2020 Q4 87.3 M $2.2 B +$86.4 M $25.24 156
2020 Q3 82.4 M $3.11 B -$164 M $37.71 156
2020 Q2 86.2 M $3.69 B +$665 M $42.82 168
2020 Q1 71.4 M $1.39 B +$45.7 M $19.44 109
2019 Q4 71.6 M $1.86 B +$102 M $25.98 115
2019 Q3 64.6 M $1.76 B +$43.6 M $27.26 93
2019 Q2 63 M $1.69 B +$152 M $26.85 92
2019 Q1 57.7 M $1.66 B +$80.5 M $28.91 86
2018 Q4 55 M $1.47 B +$1.47 B $26.93 79
2016 Q1 4.03 K $115 K +$115 K $28.51 1